Articles Referencing RIGL

Zacks.com

Narrower-Than-Expected Loss at Rigel Pharma - Analyst Blog

Rigel Pharmaceuticals ' ( RIGL ) first-quarter 2013 loss of 29 cents per share was narrower than both the Zacks Consensus Estimate as well as the year-ago quarter loss of 32 cents. The... Read >>

Zacks.com

AZN Reports Data on Fostamatinib - Analyst Blog

AstraZeneca ( AZN ) announced top-line data from the phase III study (OSKIRA-1: n = 923) on its rheumatoid arthritis (RA) candidate fostamatinib. The study assessed the safety and efficacy... Read >>

Benzinga

Mid-Morning Market Update: Markets Tumble, F5 Networks Cuts View

Following the market opening Friday, the Dow traded down 0.89 percent to 14,475.45 while the NASDAQ dropped 1.40 percent to 3,179.67. The S&P also fell, declining 1.08 percent... Read >>

NASDAQ.com News

Pre-Market Most Active for Apr 5, 2013 : BAC, RIGL, QQQ, CSCO, MT, FB, SIRI, INTC, NOK, RDS/A, BDN, STO

The NASDAQ 100 Pre-Market Indicator is down -20.23 to 2,774.69. The total Pre-Market volume is currently 7,166,894 shares traded. The following are the most active stocks for the... Read >>

Zacks.com

Loss at Rigel Narrower Than Expected - Analyst Blog

Rigel Pharmaceuticals ' ( RIGL ) fourth quarter 2012 loss of 30 cents per share was narrower than the Zacks Consensus Estimate of a loss of 32 cents and the year-ago loss of 36 cents. The... Read >>

Zacks.com

Company News for March 06, 2013 - Corporate Summary

•    Shares of QUALCOMM, Inc. (NASDAQ: QCOM ) surged 2% on Tuesday after the company announced that it has raised its dividend from 25 cents to 35 cents. Moreover, it also... Read >>

NASDAQ.com News

Pre-Market Earnings Report for March 5, 2013 : BNS, QUAD, HEES, RIGL, MEMP, CKP, CVGW, MCGC, BKR

The following companies are expected to report earnings prior to market open on 03/05/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Bank of Nova Scotia ( ... Read >>

Benzinga

Mid-Afternoon Market Update: SolarCity Hangs on to Gains, Rigel Pharma Continues to Hurt

Toward the end of trading Thursday, the Dow traded down 0.71 percent to 13,151.63 while the NASDAQ fell 0.97 percent to 2,984.68. The S&P also fell, decreasing 0.81 percent to 1,416.98.... Read >>

Benzinga

Mid-Day Market Update: Markets Go Red, SolarCity IPO a Success

Mid-way through trading Thursday, the Dow traded down 0.38 percent to 13,194.63 while the NASDAQ fell 0.67 percent to 2,993.63. The S&P also fell, decreasing 0.55 percent to 1,420.69. ... Read >>

Benzinga

Mid-Morning Market Update: Markets Cautiously Rising, Best Buy Boosts

Following the market opening Thursday, the Dow traded up 0.01 percent to 13,247.25 while the NASDAQ rose 0.29 percent to 3,022.44. The S&P also rose, increasing 0.07 percent... Read >>

NASDAQ.com News

Pre-Market Most Active for Dec 13, 2012 : CLWR, NOK, BBY, BAC, ERIC, WMB, ACMP, S, RFMD, RIMM, AAPL, RIGL

The NASDAQ 100 Pre-Market Indicator is down -1.47 to 2,673.1. The total Pre-Market volume is currently 23,289,294 shares traded. The following are the most active stocks for the pre-market... Read >>

NASDAQ.com News

Pre-Market Most Active for Oct 3, 2012 : WLP, PCS, SRPT, QQQ, BAC, NOK, S, VOD, BBY, RIGL, RIMM, SIRI

The NASDAQ 100 Pre-Market Indicator is up 2.88 to 2,802.17. The total Pre-Market volume is currently 5,638,131 shares traded. The following are the most active stocks for the pre-market... Read >>

Trading Markets

3 Nasdaq Stocks for Active Investors

Today's look at stocks pulling back above the 200-day moving average includes a pair of biotechnology stocks, known for their volatility and ability to make big moves, and an... Read >>

Kapitall

Covidien Spins Off Drug Company: 5 Drug Makers Hedge Funds Want Most

( Written by Rebecca Lipman. Institutional data sourced from Fidelity.) Covidien Plc ( COV ) plans to spin off its pharmaceuticals division from its surgical products in order to create a... Read >>

Kapitall

The New Pfizer: 6 Drug Companies with Bullish Short Trends

(Written by Rebecca Lipman. Short data sourced from Yahoo! Finance.) Pfizer, the world’s largest drug maker, is having a very interesting week. The company has authorized a $10 billion share... Read >>

Displaying 1-15 of 17
<< first < previous 1 2 next > last >>